Doranne L. Hilarius
Beverwijk, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Toward Fit-for-Purpose Data for Drug Assessment in Non-small Cell Lung Cancer: A Core Dataset.
Journal: Clinical pharmacology and therapeutics
Published: March 19, 2026
Repurposing Registries: Completeness of Real-World Data for Regulatory and HTA Purposes in Three Cancer-Focused Registries.
Journal: Clinical pharmacology and therapeutics
Published: January 06, 2026
The effectiveness of pembrolizumab maintenance with or without pemetrexed after induction treatment for advanced non-squamous Non-Small-Cell Lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: February 28, 2025
Reassessing pembrolizumab dosing in NSCLC for methodological and clinical accuracy - Author's reply.
Reassessing pembrolizumab dosing in NSCLC for methodological and clinical accuracy - Author's reply.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: February 18, 2025
Real-world overall survival after alternative dosing for pembrolizumab in the treatment of non-small cell lung cancer: A nationwide retrospective cohort study with a non-inferiority primary objective.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: June 18, 2024
Correction: Individual patient data to allow a more elaborated comparison of trial results with real-world outcomes from second-line immunotherapy in NSCLC.
Journal: BMC medical research methodology
Published: January 28, 2023
Real-world Outcomes of Ipilimumab Plus Nivolumab Combination Therapy in a Nation-wide Cohort of Advanced Melanoma Patients in the Netherlands.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: December 09, 2022
A comparison of the effectiveness of different doses of tocilizumab and sarilumab in the treatment of severe COVID-19: a natural experiment due to drug shortages.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: December 01, 2022
Population mortality in advanced melanoma patients with and without response and progression; data from the Dutch Melanoma Treatment Registry.
Journal: European journal of cancer (Oxford, England : 1990)
Published: October 28, 2022
End-of-Life Use of Systemic Therapy in Patients With Advanced Melanoma: A Nationwide Cohort Study.
Journal: JCO oncology practice
Published: August 09, 2022
Long-term survival of patients with advanced melanoma treated with BRAF-MEK inhibitors.
Journal: Melanoma research
Published: June 15, 2022
Individual patient data to allow a more elaborated comparison of trial results with real-world outcomes from first-line immunotherapy in NSCLC.
Journal: BMC medical research methodology
Published: March 27, 2022
Last Updated: 09/26/2026